Bisphosphonate-Induced Osteonecrosis of the Jaws (BIONJ)
- 3 Downloads
The risk of osteonecrosis of the jaw is greater for patients receiving intravenous bisphosphonates for cancer than for patients receiving oral bisphosphonates for osteoporosis or Paget’s disease.
Materials and Methods
This article provides a review of the treatment of Bisphosphonate induced osteonecrosis of jaws.
Bisphonates associated jaw necrosis and its relation to dentisitry and maxillofacial surgery has become common now a days. Proper diagnosis and treatment may help the patients health getting worsen.
KeywordsBisphosphonate-related osteonecrosis BIONJ Bisphosphonates in maxillofacial surgery Bisphosphonate-induced osteonecrosis
- 1.Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B, American Association of Oral and Maxillofacial Surgeons (2009) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws—2009 update. J Oral Maxillofac Surg 67(5 Suppl):2–12Google Scholar
- 2.Marx RE, Stern DS (2002) Oral and maxillofacial pathology: a rationale for diagnosis and treatment. Quintessence, ChicagoGoogle Scholar
- 6.Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons (2007) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 65(3):369–376CrossRefGoogle Scholar
- 7.Edwards BJ, Hellstein JW, Jacobsen PL, Kaltman S, Mariotti A, Migliorati CA, American Dental Association Council on Scientific Affairs Expert Panel on Bisphosphonate-Associated Osteonecrosis of the Jaw (2008) Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy: an advisory statement from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc 139(12):1674–1677CrossRefGoogle Scholar
- 9.Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O’Ryan F, American Association of Oral and Maxillofacial Surgeons (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw–2014 update. J Oral Maxillofac Surg 72(10):1938–1956CrossRefGoogle Scholar
- 12.Lin JH, Russell G, Gertz B (1999) Pharmacokinetics of alendronate: an overview. Int J Clin Pract Suppl 101:18–26Google Scholar
- 13.Green JR (2004) Bisphosphonates: preclinical review. Oncologist 9(Suppl 4):313Google Scholar
- 18.(2006) Oral and Intravenous Bisphosphonate-induced osteonecrosis of the jaws. Quintessence, Chicago, pp 64–72Google Scholar
- 20.Marx RE (2008) Bisphosphonate-induced osteonecrosis of the jaws: a challenge, a responsibility, and an opportunity. Int J Periodontics Restor Dent 28(1):5–6Google Scholar